Connect Biopharma Holdings (CNTB) Operating Leases (2020 - 2026)
Connect Biopharma Holdings (CNTB) posted Operating Leases of $693000.0 for Q1 2026, up 88.32% sequentially from $368000.0 in Q4 2025, and down 26.28% YoY from $940000.0 in Q1 2025.
Connect Biopharma Holdings (CNTB) Operating Leases (2020 - 2026) Analysis & Trends
Connect Biopharma Holdings has reported Operating Leases for 7 years, with the latest figure at $693000.0 in Q1 2026.
- Quarterly Operating Leases fell 26.28% year-over-year to $693000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $693000.0 (down 26.28% YoY) and the FY2025 annual result came in at $368000.0, up 1433.33% from the prior year.
- Operating Leases improved to $693000.0 in Q1 2026 per CNTB's latest filing, from $368000.0 in the prior quarter.
- Over five years, Operating Leases peaked at $940000.0 in Q1 2025 and troughed at $24000.0 in Q4 2024.
- A 5-year average of $461689.9 and a median of $335000.0 in 2022 frame the typical range for Operating Leases.
- The sharpest annual moves came in 2024 and 2025: Operating Leases plunged 86.67% in 2024, then jumped 1433.33% in 2025.
- Over 5 years, Operating Leases stood at $239589.3 in 2022, then retreated by 24.87% to $180000.0 in 2023, then slumped by 86.67% to $24000.0 in 2024, then surged by 1433.33% to $368000.0 in 2025, then surged by 88.32% to $693000.0 in 2026.
- According to Business Quant data, Operating Leases over the past three periods registered $693000.0, $368000.0, and $781000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.95 Bn | 132.10 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.71 Bn | 78.72 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.71 Bn | 60.52 Bn | 1.37 Bn |
| 4 | Moderna | 60.45 Bn | 55.31 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.24 Bn | 37.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.64 Bn | 10.25 Bn | 668.28 Mn |
| 8 | Insmed | 27.61 Bn | 26.45 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - |
| 10 | Connect Biopharma Holdings | 145.26 Mn | 145.26 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 596,000.00 |
| Mar 31, 2026 | 693,000.00 |
| Dec 31, 2025 | 368,000.00 |
| Sep 30, 2025 | 781,000.00 |
| Jun 30, 2025 | 870,000.00 |
| Mar 31, 2025 | 940,000.00 |
| Dec 31, 2024 | 24,000.00 |
| Jun 30, 2024 | 325,000.00 |
| Dec 31, 2023 | 180,000.00 |
| Jun 30, 2023 | 323,000.00 |
| Dec 31, 2022 | 239,589.35 |
| Jun 30, 2022 | 335,000.00 |
| Dec 31, 2021 | 25,494.76 |
| Dec 31, 2020 | 46,626.03 |